Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FRWC8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,570
Award facts
- Contract value 100% obligated
- $21,570.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes with a ceiling value of $21,570.48 under a firm fixed-price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and no set-aside designation was utilized. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a comprehensive global pharmaceutical support vehicle through its prime indefinite delivery contract with DLA, enabling the supply of a broad range of pharmaceutical products and medical supplies to support defense health operations worldwide. The delivery order for Dupixent, a specialty pharmaceutical product, demonstrates the company's role in fulfilling federal medical supply requirements through competitive procurement practices. As part of DLA's strategic approach to pharmaceutical prime vendor contracting, AmerisourceBergen is positioned among multiple contractors selected to serve various regions and government healthcare customers, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DB25FRWC8?
SPE2DB25FRWC8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FRWC8 worth?
The government has obligated $21,570 on SPE2DB25FRWC8.
Is contract SPE2DB25FRWC8 an order under another contract?
Yes. SPE2DB25FRWC8 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRWC8 competed?
The extent of competition for SPE2DB25FRWC8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award